Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Vbi Vaccines Inc CS (VBIV)

3.07   0.17 (5.86%) 07-29 04:34
Open: 2.86 Pre. Close: 2.9
High: 3.085 Low: 2.86
Volume: 2,025,577 Market Cap: 780M
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology in Israel, the United States, and internationally. The company offers Sci-B-Vac, a prophylactic hepatitis B vaccine for adults, children, and newborns. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for a functional cure of chronic hepatitis B. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that mimic the target virus to elicit a potent immune response. Its lead eVLP program candidates include VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study; and VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial. In addition, the company engages in the development of vaccine platforms and products for licensing to pharmaceutical companies and biotechnology companies. It primarily serves physicians and pharmacists through direct sales. VBI Vaccines Inc. has collaboration and license agreements with Brii Biosciences Limited; and GlaxoSmithKline Biologicals S.A. It also has a collaboration with the National Research Council of Canada to develop pan-coronavirus vaccine candidate targeting COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is headquartered in Cambridge, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.097 - 3.118 3.118 - 3.136
Low: 2.812 - 2.837 2.837 - 2.859
Close: 3.029 - 3.071 3.071 - 3.108

Technical analysis

as of: 2021-07-28 4:47:49 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 4.37     One year: 5.03
Support: Support1: 2.83    Support2: 2.35
Resistance: Resistance1: 3.74    Resistance2: 4.31
Pivot: 3.05
Moving Average: MA(5): 2.99     MA(20): 3.11
MA(100): 3.23     MA(250): 3.24
MACD: MACD(12,26): -0.14     Signal(9): -0.14
Stochastic oscillator: %K(14,3): 29.85     %D(3): 25.23
RSI: RSI(14): 44.06
52-week: High: 5.22  Low: 2.07  Change(%): -19.2
Average Vol(K): 3-Month: 323170  10-Days: 202810

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
VBIV has closed below upper band by 44.6%. Bollinger Bands are 52.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to VBIV's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 31 Dec 1969


Wed, 31 Dec 1969


Wed, 31 Dec 1969


Wed, 31 Dec 1969


Wed, 31 Dec 1969


Wed, 31 Dec 1969


Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 254
Shares Float (M) 177
% Held by Insiders 3.27
% Held by Institutions 53.23
Shares Short (K) 35,220
Shares Short P. Month (K) 37,710

Stock Financials

EPS -0.235
EPS Est This Year -0.890
EPS Est Next Year -1.010
Book Value (p.s.) 0.710
Profit Margin
Operating Margin -5269.38
Return on Assets (ttm) -18.9
Return on Equity (ttm) -43.6
Qtrly Rev. Growth -27.5
Gross Profit (p.s.) -0.032
Sales Per Share 0.004
EBITDA (p.s.) -0.190
Qtrly Earnings Growth
Operating Cash Flow (M) -46
Levered Free Cash Flow (M) -26

Stock Valuations

PE Ratio -13.06
PEG Ratio
Price to Book value 4.32
Price to Sales 824.07
Price to Cash Flow -16.95

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date 2012-12-27
Ex-Dividend Date 2012-02-04
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.